President Donald Trump has taken office, and organizations can stay ahead of US policy changes and strategic shifts that may impact operations under the new presidential administration. McDermott’s cross-practice team, along with health policy consultancy McDermott+, is providing timely analysis and proactive guidance across key sectors, including regulatory enforcement, healthcare, antitrust, and more.
Refer to our curated collection of articles, webinars, and commentary below to help you understand the implications of the new administration’s policies and prepare for the evolving regulatory landscape.
INSIGHTS
New Tariff Developments: China, Canada, and Mexico: On February 1, 2025, using authority under the International Emergency Economic Powers Act and other legal provisions, President Trump signed three executive orders imposing new tariffs on all goods from Canada, Mexico, and China effective February 4. Clients doing business in China, and potentially in Canada and Mexico depending on the outcome of the negotiations now underway, should be prepared for increased costs, along with potential disruptions and modifications to supply chains.
Responding to Stop Work Orders Implementing Recent Executive Orders: Many companies that hold or support federal contracts, grants, and other awards have received so-called “stop work orders” or other directives to cease certain activities in connection with their federal work. Recent Temporary Restraining Orders (TROs) simplify the playbook for responding to stop work orders and highlight the executive branch’s overreach in pausing disbursements and obligations under federal awards.
How Employers and Healthcare Providers Can Navigate ICE: Despite the anticipation of increased enforcement of US immigration laws, the rules and practical advice related to an employer’s legal duties under the Immigration Reform and Control Act and what to do if US Immigration and Customs Enforcement (ICE) officers present themselves at your place of business have not changed. We provide a brief overview, proactive suggestions, and practical tips for employers, as well as for healthcare providers whose patients may be the target of an ICE visit.
McDermott+ First 100 Days Resource Center: It will be crucial to stay ahead of health policy changes and strategic shifts that may impact operations under the new administration. Understand the implications of the new administration’s policies and prepare your business for the evolving healthcare landscape in 2025 and beyond.
Unpacking Biden’s Last-Minute Antitrust Worker Protections: In the final week of the Biden administration, the antitrust enforcement agencies – the Federal Trade Commission (FTC) and the US Department of Justice (DOJ) – released two policies potentially impacting labor markets. We expect the new Trump administration will revisit these last-minute policy releases.
Data Privacy and Cybersecurity Developments We Are Watching in 2025: What will the second Trump administration bring when it comes to federal consumer privacy regulation? Between chatter of shuttering entire agencies and shifting enforcement priorities, it is clear that this year will see a change in the way that the federal government approaches its role in the consumer privacy arena.
How Cross-Border M&A May Be Impacted by Incoming Tax Reform: President-elect Trump did not present a formal tax proposal during his campaign, but he highlighted key areas of tax policy that will impact individuals and businesses, with significant implications for cross-border mergers and acquisitions.
AI and the Law: Emerging Trends in Enforcement: The US federal government has taken various steps to address the rapid development and deployment of AI technologies, with recent actions by federal and state regulators offering insights into AI enforcement priorities.
Peering Into the Crystal Ball: Crypto Enforcement in a Second Trump Term: The reelection of President-elect Trump – who has signaled an intention to substantially reduce regulatory scrutiny over crypto – will change recent crypto enforcement priorities, as well as the governmental entities and units advancing them.
Post-Election Outlook: Pharmacy Regulation: There are important implications for the outlook for pharmacy regulation under the second incoming Trump administration and a unified Republican Congress, as well as state-level pharmacy policies that may advance as Republican public policy momentum builds.
What a Second Trump Term Means for Antitrust Enforcement: While it appears that the new administration will be good for business, especially for companies planning to expand through mergers and acquisitions, this client alert examines what is likely to change and what is likely to stay the same in antitrust enforcement throughout the next four years.
Lame Duck 2024 Update: Healthcare Priorities: With Republicans controlling the White House, US Senate, and US House of Representatives in 2025, each side will need to consider whether negotiating a compromise during the lame duck session is ultimately politically better than what they could achieve next year.
IN THE NEWS
Merger Remedies Back in Vogue Under Trump, The Deal
Calif. Law Firms Gear Up for Newsom-Trump Showdown in ’25, Law360
Bank of America, Citigroup Exit Climate Alliance as Trump Policies Shift Energy Priorities, Benzinga
Google, Meta in the Antitrust Crosshairs for 2025, Law360
On Tap in NY: Diddy, Trump and a New Manhattan Top Cop, Law360
What’s Ahead for AI Regulation in 2025?, Modern Healthcare
2025 Outlook: What’s Driving Health Equity Work Amid Trump 2.0 Uncertainty?, Fierce Healthcare
What the 2024 Election Could Mean for State Tax Policy, Tax Notes
Brighter M&A Outlook Prompts Poison Pill Reevaluations, The Deal
Trump Names FTC Chair Who’s Been Thorn in Side of Lina Khan, Corporate Counsel
US Renewable Energy Tax Credits Should be Safe Despite Election Results, PV Tech
Antitrust Practitioners Expect Greater Acceptance of Structural and Behavioral Remedies in Trump Administration, Mergermarket
Corporate Citizenship Gets New Post-Election Life, Forbes
Renewable Energy Investors Are Gearing Up for Another Big Year, CleanTechnica
No, FBI Checks Aren’t Required for Trump’s Nominees. Yes, it’s Concerning., Vox
Health Policy Predictions for Trump’s Second Administration, Law360
Will the Affordable Care Act Survive a Trump Presidency?, Benefits News
UN Treaty Enacting Cybercrime Standards Likely to Face Headwinds in US, Other Countries, Legaltech News
Guest Post: The Board’s Post-Election Oversight of Corporate Compliance, The D&O Diary
Experts: FDA, Not FTC, May Take Orange Book Lead Under Trump, Inside Health Policy
Wall Street is Gearing Up for an M&A Boom Under Trump. These Companies Could Be Attractive Targets, CNBC
What a Second Trump Term Could Mean for Regulation of AI, Tech Brew
Painter on Trump’s Legal Proceedings, Gulati on Study of Trump-Appointed Judges, Bergman on AI and Teen Suicide, and Much More, WGN Radio 720
Workplace Policies Poised for Seismic Shakeup Post-Election, Work Life
From AI to Hardware Costs: Enterprise Tech Leaders Prepare for Trump 2.0, The Wall Street Journal
Corporate Board Service Just Became a Whole Lot Busier, Forbes
IRA Repeal is Unlikely, Analysts Say, But There Could Be Some ‘Pruning’, Offshore
How Trump’s Triumph Will Turbocharge America’s Left-Leaning Tech Giants, The Telegraph
What a New Trump Mandate Could Mean for American Data Privacy Rights, TechRadar.com
Board Support of Management During Post-Election Volatility, Agenda
Merger Guidelines Will Likely Go Away Under Trump, Legal Dive
Trump Likely to Keep Up Antitrust Enforcement, but Dial Back the Antagonism, Corporate Counsel
Trump Expected to Shift Course on Antitrust, Stop Google Breakup, Reuters
Trump’s Return to the White House: The Legal Industry Reacts, The American Lawyer
Trump Return Will Slow, Not Stop, US Clean Energy Boom, Reuters
Big Law Leaders, Dealmakers Optimistic About M&A Deal Flow Under Trump, With Caveats, The American Lawyer
[View source.]
